U. Jarry

Genomic characteristics and clinical significance of CD56+ Circulating Tumor Cells in Small Cell Lung Carcinoma

M. Aubry, T. Guillaudeux, M. Logotheti, 2022, bioRxiv.

In vitro long term differentiation and functionality of three-dimensional bioprinted primary human hepatocytes: application for in vivo engraftment

G. Baffet, S. Langouët, V. Legagneux, 2022, Biofabrication.

A Preclinical Validation of Iron Oxide Nanoparticles for Treatment of Perianal Fistulizing Crohn’s Disease

L. Motte, E. Ogier-Denis, P. Eliat, 2022, International journal of molecular sciences.

Genomic characteristics and clinical significance of CD56+ circulating tumor cells in small cell lung cancer

M. Aubry, T. Guillaudeux, M. Logotheti, 2023, bioRxiv.

Orthotopic model of lung cancer: isolation of bone micro-metastases after tumor escape from Osimertinib treatment

T. Guillaudeux, R. Pedeux, R. Pineau, 2021, BMC cancer.

The Ouzo effect: A tool to elaborate high-payload nanocapsules.

F. Gauffre, S. Dutertre, O. Mongin, 2020, Journal of controlled release : official journal of the Controlled Release Society.

Radiosensitizing Fe-Au Nanocapsules (Hybridosomes®) increase survival of GL261 brain tumor-bearing mice treated by radiotherapy.

P. Eliat, F. Gauffre, T. Guillaudeux, 2021, Nanomedicine : nanotechnology, biology, and medicine.

Genomic characteristics and clinical significance of CD56+ Circulating Tumor Cells in Small Cell Lung Carcinoma

M. Aubry, A. Chatziioannou, T. Guillaudeux, 2022 .

The Identification of New c-FLIP Inhibitors for Restoring Apoptosis in TRAIL-Resistant Cancer Cells

T. Guillaudeux, Samia Aci-Sèche, P. Lafite, 2024, Current issues in molecular biology.

Afatinib or Bevacizumab in combination with Osimertinib efficiently control tumor development in orthotopic murine models of non-small lung cancer

R. Pedeux, C. Ricordel, L. Chaillot, 2024, PloS one.